Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease
2018 · Nature Communications · 38 citations
https://doi.org/10.1038/s41467-018-04420-4
Y
Yuki Hayashi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
1.1K
Citations
15
h-index
17
i10-index
Yuki Hayashi is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Inflammatory Bowel Disease & COVID-19 Clinical Research Studies & Gastric Cancer Management and Outcomes. The author has an h-index of 15, co-authored 50 publications.
ORCID: 0000-0001-8680-404XPapers by this author
worksInterim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)
2022 · Journal of Gastroenterology · 10 citations
https://doi.org/10.1007/s00535-022-01851-1
The improvement of a refractory enterocutaneous fistula with colchicine in a patient with Crohn’s disease who had an MEFV gene mutation
2024 · Clinical Journal of Gastroenterology · 0 citations
https://doi.org/10.1007/s12328-024-02061-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat